212 related articles for article (PubMed ID: 26615599)
1. The impact of fibromyalgia symptoms on brain morphometry.
Diaz-Piedra C; Guzman MA; Buela-Casal G; Catena A
Brain Imaging Behav; 2016 Dec; 10(4):1184-1197. PubMed ID: 26615599
[TBL] [Abstract][Full Text] [Related]
2. Subtle changes of gray matter volume in fibromyalgia reflect chronic musculoskeletal pain rather than disease-specific effects.
Sundermann B; Dehghan Nayyeri M; Pfleiderer B; Stahlberg K; Jünke L; Baie L; Dieckmann R; Liem D; Happe T; Burgmer M
Eur J Neurosci; 2019 Dec; 50(12):3958-3967. PubMed ID: 31448468
[TBL] [Abstract][Full Text] [Related]
3. Histological Underpinnings of Grey Matter Changes in Fibromyalgia Investigated Using Multimodal Brain Imaging.
Pomares FB; Funck T; Feier NA; Roy S; Daigle-Martel A; Ceko M; Narayanan S; Araujo D; Thiel A; Stikov N; Fitzcharles MA; Schweinhardt P
J Neurosci; 2017 Feb; 37(5):1090-1101. PubMed ID: 27986927
[TBL] [Abstract][Full Text] [Related]
4. Gray Matter Brain Alterations in Temporomandibular Disorder Tested in a Population Cohort and Three Clinical Samples.
Domin M; Grimm NK; Klepzig K; Schmidt CO; Kordass B; Lotze M
J Pain; 2021 Jun; 22(6):739-747. PubMed ID: 33529707
[TBL] [Abstract][Full Text] [Related]
5. Brain Structural Changes During Juvenile Fibromyalgia: Relationships With Pain, Fatigue, and Functional Disability.
Suñol M; Payne MF; Tong H; Maloney TC; Ting TV; Kashikar-Zuck S; Coghill RC; López-Solà M
Arthritis Rheumatol; 2022 Jul; 74(7):1284-1294. PubMed ID: 35076177
[TBL] [Abstract][Full Text] [Related]
6. Brain gray matter alterations in Chinese patients with chronic knee osteoarthritis pain based on voxel-based morphometry.
Liao X; Mao C; Wang Y; Zhang Q; Cao D; Seminowicz DA; Zhang M; Yang X
Medicine (Baltimore); 2018 Mar; 97(12):e0145. PubMed ID: 29561420
[TBL] [Abstract][Full Text] [Related]
7. White and gray matter abnormalities in the brain of patients with fibromyalgia: a diffusion-tensor and volumetric imaging study.
Lutz J; Jäger L; de Quervain D; Krauseneck T; Padberg F; Wichnalek M; Beyer A; Stahl R; Zirngibl B; Morhard D; Reiser M; Schelling G
Arthritis Rheum; 2008 Dec; 58(12):3960-9. PubMed ID: 19035484
[TBL] [Abstract][Full Text] [Related]
8. Association of Alterations in Gray Matter Volume With Reduced Evoked-Pain Connectivity Following Short-Term Administration of Pregabalin in Patients With Fibromyalgia.
Puiu T; Kairys AE; Pauer L; Schmidt-Wilcke T; Ichesco E; Hampson JP; Napadow V; Clauw DJ; Harris RE
Arthritis Rheumatol; 2016 Jun; 68(6):1511-21. PubMed ID: 26816332
[TBL] [Abstract][Full Text] [Related]
9. Fibromyalgia is characterized by altered frontal and cerebellar structural covariance brain networks.
Kim H; Kim J; Loggia ML; Cahalan C; Garcia RG; Vangel MG; Wasan AD; Edwards RR; Napadow V
Neuroimage Clin; 2015; 7():667-77. PubMed ID: 25844321
[TBL] [Abstract][Full Text] [Related]
10. Decreased gray matter volumes in the cingulo-frontal cortex and the amygdala in patients with fibromyalgia.
Burgmer M; Gaubitz M; Konrad C; Wrenger M; Hilgart S; Heuft G; Pfleiderer B
Psychosom Med; 2009 Jun; 71(5):566-73. PubMed ID: 19414621
[TBL] [Abstract][Full Text] [Related]
11. Understanding the Association of Fatigue With Other Symptoms of Fibromyalgia: Development of a Cluster Model.
Lukkahatai N; Walitt B; Espina A; Gelio A; Saligan LN
Arthritis Care Res (Hoboken); 2016 Jan; 68(1):99-107. PubMed ID: 26017904
[TBL] [Abstract][Full Text] [Related]
12. Gray matter abnormalities associated with fibromyalgia: A meta-analysis of voxel-based morphometric studies.
Shi H; Yuan C; Dai Z; Ma H; Sheng L
Semin Arthritis Rheum; 2016 Dec; 46(3):330-337. PubMed ID: 27989500
[TBL] [Abstract][Full Text] [Related]
13. Agomelatine in the treatment of fibromyalgia: a 12-week, open-label, uncontrolled preliminary study.
Bruno A; Micò U; Lorusso S; Cogliandro N; Pandolfo G; Caminiti M; Zoccali RA; Muscatello MR
J Clin Psychopharmacol; 2013 Aug; 33(4):507-11. PubMed ID: 23764682
[TBL] [Abstract][Full Text] [Related]
14. Conditioned pain modulation in patients with nonspecific chronic back pain with chronic local pain, chronic widespread pain, and fibromyalgia.
Gerhardt A; Eich W; Treede RD; Tesarz J
Pain; 2017 Mar; 158(3):430-439. PubMed ID: 27902566
[TBL] [Abstract][Full Text] [Related]
15. Executive function in chronic pain patients and healthy controls: different cortical activation during response inhibition in fibromyalgia.
Glass JM; Williams DA; Fernandez-Sanchez ML; Kairys A; Barjola P; Heitzeg MM; Clauw DJ; Schmidt-Wilcke T
J Pain; 2011 Dec; 12(12):1219-29. PubMed ID: 21945593
[TBL] [Abstract][Full Text] [Related]
16. Altered gray matter volume in sensorimotor and thalamic regions associated with pain in localized provoked vulvodynia: a voxel-based morphometry study.
Bhatt RR; Gupta A; Rapkin A; Kilpatrick LA; Hamadani K; Pazmany E; Van Oudenhove L; Stains J; Aerts L; Enzlin P; Tillisch K; Mayer EA; Labus JS
Pain; 2019 Jul; 160(7):1529-1540. PubMed ID: 30817440
[TBL] [Abstract][Full Text] [Related]
17. No consistent difference in gray matter volume between individuals with fibromyalgia and age-matched healthy subjects when controlling for affective disorder.
Hsu MC; Harris RE; Sundgren PC; Welsh RC; Fernandes CR; Clauw DJ; Williams DA
Pain; 2009 Jun; 143(3):262-267. PubMed ID: 19375224
[TBL] [Abstract][Full Text] [Related]
18. Brain structural alterations in MDD patients with gastrointestinal symptoms: Evidence from the REST-meta-MDD project.
Liu PH; Li Y; Zhang AX; Sun N; Li GZ; Chen X; Bai TJ; Bo QJ; Chen GM; Chen NX; Chen TL; Chen W; Cheng C; Cheng YQ; Cui XL; Duan J; Fang YR; Gong QY; Guo WB; Hou ZH; Hu L; Kuang L; Li F; Li KM; Li T; Liu YS; Liu ZN; Long YC; Luo QH; Meng HQ; Peng DH; Qiu HT; Qiu J; Shen YD; Shi YS; Wang F; Wang K; Wang L; Wang X; Wang Y; Wu XP; Wu XR; Xie CM; Xie GR; Xie HY; Xie P; Xu XF; Yang H; Yang J; Yao JS; Yao SQ; Yin YY; Yuan YG; Zhang H; Zhang L; Zhang ZJ; Zhou RB; Zhou YT; Zhu JJ; Zou CJ; Si TM; Zuo XN; Yan CG; Zhang KR
Prog Neuropsychopharmacol Biol Psychiatry; 2021 Dec; 111():110386. PubMed ID: 34119573
[TBL] [Abstract][Full Text] [Related]
19. Clustering a large Spanish sample of patients with fibromyalgia using the Fibromyalgia Impact Questionnaire-Revised: differences in clinical outcomes, economic costs, inflammatory markers, and gray matter volumes.
Pérez-Aranda A; Andrés-Rodríguez L; Feliu-Soler A; Núñez C; Stephan-Otto C; Pastor-Mira MA; López-Roig S; Peñacoba C; Calandre EP; Slim M; Salgueiro M; Feixas G; Luciano JV
Pain; 2019 Apr; 160(4):908-921. PubMed ID: 30586023
[TBL] [Abstract][Full Text] [Related]
20. Gray Matter Abnormalities in Non-comorbid Medication-naive Patients with Major Depressive Disorder or Social Anxiety Disorder.
Zhao Y; Chen L; Zhang W; Xiao Y; Shah C; Zhu H; Yuan M; Sun H; Yue Q; Jia Z; Zhang W; Kuang W; Gong Q; Lui S
EBioMedicine; 2017 Jul; 21():228-235. PubMed ID: 28633986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
